S164-117 · 117th Congress
Signed
Signed Apr 23, 2021Advancing Education on Biosimilars Act of 2021
Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.
VOTE BREAKDOWN
Final passage · 288 politicians tracked
276
YEA
6
NAY
0
PRESENT
6
NOT VOTING
Dem YEA 140Rep NAY 6Rep YEA 136
BY PARTY · ✕ NAY ← | → YEA ✓
DEM
0
140
REP
6
136
MONEY ON THIS BILL
Which donor industries fund each side of the vote — total contributions from that industry to those members, all cycles · plus lobbying activity in affected industries
⬆ YEA voters — top donor industries
- 1. Lawyers & Lobbyists$167.1M
- 2. Health Services$119.9M
- 3. Securities & Investment$119.2M
⬇ NAY voters — top donor industries
- 1. Lawyers & Lobbyists$834K
- 2. Construction & Engineering$706K
- 3. Health Services$636K
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
Dollar figures are each industry's total contributions to those members across all tracked cycles — not money given for this specific bill. Statistical patterns in public records; correlation, not causation.
INDIVIDUAL VOTES
Recorded positions for tracked politicians
SPONSORS
Margaret Wood Hassan
D-NH · Primary
1 COSPONSOR
REPUBLICAN● 1 R
SPONSOR FUNDING
Top industries funding Hassan
Lawyers & Lobbyists20%
Lawyers & Lobbyists 20% of classified donations
Securities & Investment11%
Securities & Investment 11% of classified donations
Health Services9%
Health Services 9% of classified donations
Party & Leadership9%
Party & Leadership 9% of classified donations
Technology7%
Technology 7% of classified donations
TRAIL AI
The Advancing Education on Biosimilars Act of 2021 establishes education and awareness programs regarding biosimilar medications, which are biologically derived drugs comparable to existing approved biologics. The bill passed with broad bipartisan support, receiving 275 votes in favor and 6 opposed, with all Democratic votes in support and Republican votes split 135-6 in favor. The legislation was signed into law.
Based on public voting records. Does not imply causation.
TIMELINE
INTRODUCEDFeb 2, 2021
PASSED SENATEMar 3, 2021
SIGNEDApr 23, 2021
DATA SOURCES
Bill data: Congress.gov · 117th–119th Congress (2021–present)
Vote records: House Clerk / Senate · 2021–present
Reflects public records. Does not imply causation.